Establishing electronic nose and IMS as a screening tool for covid-19 - We smell Covid-19!

Establishing electronic nose and IMS as a screening tool for covid-19 - We smell Covid-19! - We smell Covid-19!

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00027806

Enrollment

1000

Registered

2022-01-12

Start date

2022-04-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Infection with SARS-CoV-2

Interventions

Group 1: Patients of the Clinic for General Pediatrics and Neonatology (Wards and Emergency/ outpatient department): - Children from birth- Children from the age of 5. Patients of the Emergency Depart

Eligibility

Sex/Gender

All

Age

5 Years to 95 Years

Inclusion criteria

Inclusion criteria: - Adults and children up to the age of 5 without diagnosed acute respiratory disease - Adults and children up to the age of 5 with diagnosed acute respiratory disease

Exclusion criteria

Exclusion criteria: Age < 5 yrs

Design outcomes

Primary

Measure	Time frame
Differences regarding the profile of infected persons and a control group.	—

Secondary

Measure	Time frame
Real-time diagnostic of Covid-19-Infection	—

Countries

Germany

Contacts

Public ContactSybelle Goedicke-Fritz

Universitätsklinikum des Saarlandes, Klinik für Allgemeine Pädiatrie und Neonatologie

sybelle.goedicke-fritz@uks.eu06841/16 -28301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026